Skip to main content
Erschienen in: BMC Infectious Diseases 1/2022

Open Access 01.12.2022 | Research

Analysis of Ureaplasma urealyticum, Chlamydia trachomatis, Mycoplasma genitalium and Neisseria gonorrhoeae infections among obstetrics and gynecological outpatients in southwest China: a retrospective study

verfasst von: Ting Liu, Shu-yu Lai, Wei Zhou, Yan-ling Liu, Sha-sha Chen, Yong-mei Jiang

Erschienen in: BMC Infectious Diseases | Ausgabe 1/2022

Abstract

Background

The aim of this study was to analyze the present situation of Ureaplasma urealyticum (UU), Chlamydia trachomatis (CT), Mycoplasma genitalium (MG) and Neisseria gonorrhoeae (NG) infections among obstetrics and gynecological outpatients in southwest China.

Methods

A total of 3225 urogenital swabs were included in this study. All swabs were tested by RNA-based simultaneous amplification and testing (SAT) methods. Routine analysis of leucorrhea smear and drug susceptibility were performed in UU positive patients.

Results

Of these 3225 outpatients, the positive rate was 27.07% for UU, 4.99% for CT, 3.10% for MG, and 0.09% for NG. UU, CT, and MG infections were more common in women of reproductive age (aged 25–34 years), while NG infection was more prominent in women aged 30–34 years and over 40 years. Overall, the infection rate of UU was significantly higher than that of the other three infections, and UU also played a major role even in the mixed infections. 65.07% of the UU positive patients had negative results on routine leucorrhea smear analysis, and the remaining patients may have bacterial vaginitis (15.79%), fungal vaginitis (11.48%), trichomonas vaginitis (0.96%) or other vaginal inflammation (6.70%). We have observed that maternal UU infection can lead to low birth weight, neonatal pneumonia, and premature delivery. The results of the drug susceptibility test of UU showed a higher sensitivity to pristinamycin, doxycycline, tetracycline, clarithromycin, and josamycin (100%, 97.0%, 96.4%, 95.9%, and 95.3%, respectively), and lower sensitivity to ciprofloxacin and ofloxacin (2.4% and 4.7% respectively).

Conclusions

This study could contribute to a better understanding of the current epidemiological features of UU, CT, MG, and NG among obstetrics and gynecological outpatients in southwest China, and thus facilitate to development of the more effective intervention, prevention, and treatment of reproductive tract infection.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
UU
Ureaplasma urealyticum
CT
Chlamydia trachomatis
MG
Mycoplasma genitalium
NG
Neisseria gonorrhoeae
SAT
Simultaneous amplification and testing
PCR
Polymerase chain reaction
CIP
Ciprofloxacin
AZM
Azithromycin
CLR
Clarithromycin
ERY
Erythromycin
JOS
Josamycin
DOX
Doxycycline
OFX
Ofloxacin
PRI
Pristinamycin
TCY
Tetracycline

Introduction

Ureaplasma urealyticum (UU), Chlamydia trachomatis (CT), Mycoplasma genitalium (MG), and Neisseria gonorrhoeae (NG) are the common sexually transmitted pathogens of the reproductive tract. Previous studies have found that these pathogen infections are closely related to some gynecological diseases, such as non-gonococcal urethritis, vaginitis, cervicitis, endometritis, and even infertility [1, 2]. Generally, UU, CT, MG, and NG exist in epithelial cells and mostly do not invade the blood. UU belongs to the ureaplasma group with a circular double-stranded DNA genome. It is the smallest and simplest cell capable of self-reproduction. In recent years, UU is one of the main pathogens that cause non-gonococcal urethritis, accounting for approximately 70% of all cases [3, 4]. It’s worth noting that UU infections tends to occur in young people, especially after unclean sexual intercourse, resulting in infertility, abortion and fetal growth retardation, and other fertility problems in women of childbearing age [5, 6]. CT is an intracellular parasite that contains DNA and RNA, with an infection rate of 9.8% [7, 8]. It has a variety of serotypes, and different serotypes may cause different clinical manifestations in humans [9]. MG has the least genomic of all mycoplasmas. It also causes non-gonococcal urethritis and inflammation of the cervix or endometrium in women, with an infection rate of up to 25% [10]. NG is a gram-negative diplococcus. The main clinical manifestations of NG infection are urethritis and cervicitis [9]. Among the above four pathogens, NG is the only one that can be observed under the microscope by gram staining [11]. The clinical manifestations of patients with UU, CT, MG, and CT infections are varied, and even some patients have no obvious clinical symptoms. Therefore, a better understanding of the infection status and characteristics of these pathogens is necessary.
Simultaneous amplification and testing (SAT) is a molecular diagnostic method based on isothermal amplification of pathogen RNA, which can accurately and rapidly detect a variety of pathogens [12]. The application of SAT in the detection of RNA of pathogens of sexually transmitted diseases can overcome the disadvantages of traditional microbial culture methods. SAT method is more time-saving and more sensitive. Besides, SAT test targets the RNA of pathogens, which adequately reflects a patient’s infection status and avoids antibiotic overuse. In this study, we included 3225 outpatients in the department of obstetrics and gynecology to evaluate the prevalence characteristics of UU, CT, MG, and NG in the southwest of China using the SAT method. A better understanding of UU, CT, MG, and NG infection can help policymakers identify and address their specific strategy for the prevention, testing, and treatment of these infections.

Materials and methods

Patients

A total of 3225 outpatients who visited the obstetrics and gynecology department of West China Second University Hospital (Chengdu, China) from 2019 to 2021 for various reasons were included in this study. Urogenital swabs were collected and further detected the status of the infection of UU, CT, MG, and NG with SAT method. The average age of the patients was 31 years (range from 16 to 75 years), and the inclusion criteria were as follows: (a) Women who have no other serious diseases, such as diabetes, hypertension, kidney diseases, etc. (b) Women who have no abnormalities in uterus and ovary by B-ultrasonography examination. (c) Women who underwent UU, CT, and MG screening for the first time in the past 12 months. The exclusion criteria were as follows: (a) Women who have had vaginal medication in the past 2 weeks. (b) Women who have had antibiotics in the past 2 weeks. (c) Women who could not participate in this study for any reason. All the inspections were performed in the Department of Laboratory Medicine in West China Second University Hospital.

Specimen collection

Urogenital swabs sampling was performed by outpatient physicians. For SAT experiments, all samples were placed into the preservation solution in time according to the operational guidelines to prevent the degradation of the RNA of pathogenic microorganisms, stored at 2–8 °C and timely tested within 24 h using commercial kits (Shanghai Rendu Biotechnology Co., Ltd). Routine analysis of leucorrhea was performed by an automatic gynecological secretion analysis system (GMD-S600, DI RUI, Made in China), and drug susceptibility was performed by Mycoplasma IST 2 (bioMerieux, SA, French).

Simultaneous amplification and testing (SAT)

The SAT experiment is briefly divided into two steps, RNA extraction and amplification, using commercial kits purchased from Rendu Biotechnology Co., Ltd (Shanghai, China). RNA extraction was performed by magnetic beads methods and eluted with 40 μl detection reagent (PCR buffer, dNTP, NTP, 500 nM each of primers, 250 nM of optimization probes and internal control). For amplification, 30 μl RNA sample and 10 μl enzyme reagent (M-MLV reverse transcriptase and T7 RNA polymerase) were mixed as 40 μl final detection system. All reactions were run on an ABI 7500 detection system (Life Technologies, CA, USA) in following conditions: 40 cycles of 42 °C for 60 s. Two fluorescent dyes of FAM and VIC were used to detect the target gene and internal control respectively. Results were considered positive when a clear melting curve of the expected site was obtained (dt ≤ 35, Tm = 68 ± 5 °C).

Drug susceptibility analysis

For this experiment a commercial kit, Mycoplasma IST-2 (BioMerieux, SA, France), was used according to the manufacturer’s instructions. The kit contains strips that give information on the presence or absence of UU and also provide additional information on antibiotic susceptibility to doxycycline, josamycin, ofloxacin, erythromycin, tetracycline, ciprofloxacin, azithromycin, clarithromycin and pristinamycin. Briefly, a urogenital swab specimen was inoculated into 3 ml R1 solution (transport medium), and then combined with a vial of R2 (lyophilized powder). A 55 μL aliquot of the above solution was dispensed into each of 22 reaction wells on the reagent strip. The strips were incubated at 36 ± 2° C for 24 and 48 h. A positive test was indicated by a change in broth color from yellow to red (cut-off value is 104 color-changing units per ml).

Statistical analysis

Frequency and percentage were analyzed with SPSS 20.0 statistical software in this study. Student’s t-test and Chi-square test were used to compare categorical variables. Differences were considered to be statistically significant when p < 0.05.

Results

Prevalence of UU, CT, MG, and NG infections among the study population

Of these 3225 outpatients, a total of 873 patients were positive for UU (873/3225, 27.07%), 161 patients were positive for CT (161/3225, 4.99%), 100 patients were positive for MG (100/3225, 3.10%) and three patients were positive for NG (3/3225, 0.09%) (Fig. 1A). Among all the positive infection cases, 84 cases (84/1050, 8.00%) were found to be mixed infections, including UU + CT, UU + MG, CT + MG, CT + NG, and UU + CT + MG (Fig. 1B and C). More than half of the mixed infections were UU + CT (48/84, 57.14%). UU, CT, and MG infections were more common in women of reproductive age (aged 25–34 years), while NG infection was more prominent in women aged 30–34 years and over 40 years (Fig. 1D–G). Overall, the infection rate of UU was significantly higher than that of the other three infections, and UU also played a major role even in the mixed infections.

Clinical manifestations of UU, CT, MG, and NG infections

As shown in Fig. 2A, the most common clinical manifestations in UU positive patients were vaginitis (176/873, 20.16%), cervicitis (60/873, 6.87%) and urethritis (57/873, 6.53%). While the most common clinical manifestations of CT and MG positive patients were vaginitis (14.91% and 14.00%, respectively) and annexitis (8.70% and 8.00%, respectively). It is worth mentioning that in UU, CT and MG positive patients, the proportion of infertility patients and patients with adverse pregnancy history was relatively high. In addition, 30 ~ 40% of patients had no clinical symptoms and were found to have latent infections through routine annual gynecological examination or routine prenatal examination. For the leucorrhea analysis of UU positive patients in Fig. 2B, 65.07% of patients had normal results (negative), and the remaining patients had 15.79% for bacterial vaginitis, 11.48% for fungal vaginitis, 0.96% for trichomonas vaginitis, and 6.70% for other vaginal inflammation (WBC > 15/HPF and no fungi, trichomonas, and clue cells were found). We have also observed that maternal UU infection can lead to premature delivery (10 cases), low birth weight (2 cases), and neonatal pneumonia (4 cases) of all the 873 patients with UU infection (Fig. 2C). Overall, more than half of women with UU infection have no clinical symptoms, and about 35% of patients may have vaginal inflammation. Furthermore, as shown in Fig. 1A, the positive rate of UU is very high in outpatient patients of obstetrics and gynecology, which is about 1/4 of all patients. Therefore, routine detection of UU infection in women before pregnancy is very necessary to effectively avoid the occurrence of UU related premature delivery, low birth weight, and neonatal pneumonia.

Drug susceptibility analysis of Ureaplasma urealyticum

As shown in Table 1, a total of 169 UU samples were used to detect drug sensitivity of 9 antibodies, including ciprofloxacin (CIP), azithromycin (AZM), clarithromycin (CLR), erythromycin (ERY), josamycin (JOS), doxycycline (DOX), ofloxacin (OFX) pristinamycin (PRI) and tetracycline (TCY). The results of the drug susceptibility test of UU showed a higher sensitivity to pristinamycin, doxycycline, tetracycline, clarithromycin, and josamycin (100%, 97.0%, 96.4%, 95.9%, and 95.3%, respectively), and lower sensitivity to ciprofloxacin and ofloxacin (2.4% and 4.7% respectively). Overall, UU samples collected in this study are sensitive to tetracyclines and macrolides, and timely use of antibiotics can effectively treat UU infection in the clinic.

Discussion

The aim of this study was to detect UU, CT, MG, and NG infections in urogenital swabs from outpatients of obstetrics and gynecology in southwest China by SAT method. These findings would contribute to a better understanding of the current epidemiological features of UU, CT, MG, and NG among obstetrics and gynecological outpatients in southwest China and thus facilitate to develop a more effective intervention, prevention, and treatment of reproductive tract infection. As shown above, the infection rate of UU was significantly higher than that of the CT, MG, and NG infections and UU also played a major role even in the mixed infections. For the prevalence of UU, CT, MG, and NG in different age groups, UU, CT, and MG infections were more common in women of reproductive age (aged 25–34 years), while NG infection was more prominent in women aged 30–34 years and over 40 years. In addition, maternal UU infection may lead to premature delivery, low birth weight, and neonatal pneumonia, but not all patients with UU infection have obvious clinical manifestations [13]. These results are consistent with previous studies [5, 6, 14]. In this study, women with UU positive pregnancies were tracked, among which ten were premature, 2 were low weight, and 4 were neonatal pneumonia (As shown in Fig. 2). As for abortion, some studies found that the positive rate of UU was as high as 84.4% from the aborted tissues [13]. The perinatal infection caused by UU has become a new problem in modern obstetrics. Therefore, the SAT test is necessary for women before pregnancy. In the study of antibiotic sensitivity of UU, we found that UU was sensitive to pristinamycin, doxycycline, tetracycline, clarithromycin, and josamycin, with over 90% of all samples tested being susceptibility to these antibodies.
Additionally, in this study, the positive rate of NG was very low; this might be due to the fact that a large proportion of NG has been detected in routine leucorrhea microscopy tests. However, UU, CT, and MG are difficult to be diagnosed by routine microscopic examination of vaginal or cervical secretions. Mycoplasma and chlamydia are also difficult to be identified by microbial culture due to their slow growth and high nutrient requirements [15, 16]. In particular, the culture of MG in clinical specimens is more difficult to succeed [17]. SAT method is designed to amplify 16S rRNA in cells, thus providing a more sensitive and faster method for the detection of pathogens, such as mycobacterium tuberculosis complex, enterovirus 71, UU, CT, NG, and MG [15, 1820]. As we can see in Fig. 2 that urogenital tract infections such as UU are likely to be asymptomatic in most patients. When the immune system is weakened, or a woman is pregnant, UU infection may cause inflammation of the female reproductive system. It may also spread through the placenta into the uterine cavity and cause adverse consequences such as abortion, premature delivery or low birth weight due to the increase of progesterone and the suppression of cellular immunity. Currently, there are no vaccines related to other genitourinary pathogens other than HPV, and the research and development of the vaccine is an area worth looking forward to [21]. In general, screening for UU, CT, MG, and NG before pregnancy is important even for women without clinical symptoms to effectively promote the early diagnosis and treatment of these infections, and to avoid adverse pregnancy outcomes.
The study still has some limitations. Firstly, all the experiments were conducted at the West China Second University Hospital, which is the largest women’s and children’s hospital in southwest China, but a larger study in multiple centers may make the data more convincing. Secondly, due to the limitations of retrospective studies, the sample size of the patients with UU infection and drug susceptibility analysis is small, so it is necessary further to increase the sample size for analysis in future studies. Finally, although we can provide data on the prevalence of infections, it is difficult to draw any conclusions about the role or the mechanisms of these infections in pregnancy outcomes. Further research will be carried out on this part in the future.

Conclusion

Our study retrospectively analyzed the prevalence of UU, CT, MG, and NG infections among obstetrics and gynecological outpatients in southwest China and tracked the pregnancy outcomes in women with UU infection. Considering high prevalence of UU among the population in southwest China, urogenital infection screening is recommended in symptomatic patients with suspected urogenital infections and women pre-pregnancy. In conclusion, our study could contribute to a better understanding of the current epidemiological features of UU, CT, MG, and NG among obstetrics and gynecological outpatients in southwest China, and thus facilitate to development of more effective intervention, prevention, and treatment of urogenital infections.
Table 1
Drug susceptibility analysis of UU
https://static-content.springer.com/image/art%3A10.1186%2Fs12879-021-06966-z/MediaObjects/12879_2021_6966_Tab1_HTML.png
CIP Ciprofloxacin, AZM Azithromycin, CLR Clarithromycin, ERY Erythromycin, JOS Josamycin, DOX Doxycycline, OFX Ofloxacin, PRI Pristinamycin, TCY Tetracycline

Acknowledgements

Not applicable.

Declarations

This study was approved by the Medicine Ethics Committee of West China Second University Hospital, Sichuan University (NO.2019-18). All patients signed informed consents of this study before SAT analysis. For drug susceptibility analysis, we obtained the data from the Medical Records and Statistics Room hence informed consent waiver for this part of the study is approved by Medicine Ethics Committee of West China Second University Hospital, Sichuan University. We confirm that all methods were performed in accordance with the relevant guidelines and regulations.
Written informed consent was obtained from the patient and his parents for publication of this case report. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Verteramo R, Patella A, Calzolari E, Recine N, Marcone V, Osborn J, Chiarini F, Degener AM. An epidemiological survey of Mycoplasma hominis and Ureaplasma urealyticum in gynaecological outpatients, Rome, Italy. Epidemiol Infect. 2013;141(12):2650–7.CrossRef Verteramo R, Patella A, Calzolari E, Recine N, Marcone V, Osborn J, Chiarini F, Degener AM. An epidemiological survey of Mycoplasma hominis and Ureaplasma urealyticum in gynaecological outpatients, Rome, Italy. Epidemiol Infect. 2013;141(12):2650–7.CrossRef
2.
Zurück zum Zitat Liu Y, Zhang Y, Yang D, Xu C, Huang Y, Qing Q, Li D, Liao J, Ding Y, Zhou J, et al. Chlamydia trachomatis and mycoplasma infections in tubal pregnancy. Sci Rep. 2019;9(1):15979.CrossRef Liu Y, Zhang Y, Yang D, Xu C, Huang Y, Qing Q, Li D, Liao J, Ding Y, Zhou J, et al. Chlamydia trachomatis and mycoplasma infections in tubal pregnancy. Sci Rep. 2019;9(1):15979.CrossRef
3.
Zurück zum Zitat Khosropour CM, Manhart LE, Gillespie CW, Lowens MS, Golden MR, Jensen NL, Kenny GE, Totten PA. Efficacy of standard therapies against Ureaplasma species and persistence among men with non-gonococcal urethritis enrolled in a randomised controlled trial. Sex Transm Infect. 2015;91(5):308–13.CrossRef Khosropour CM, Manhart LE, Gillespie CW, Lowens MS, Golden MR, Jensen NL, Kenny GE, Totten PA. Efficacy of standard therapies against Ureaplasma species and persistence among men with non-gonococcal urethritis enrolled in a randomised controlled trial. Sex Transm Infect. 2015;91(5):308–13.CrossRef
4.
Zurück zum Zitat Horner P, Thomas B, Gilroy CB, Egger M, Taylor-Robinson D. Role of Mycoplasma genitalium and Ureaplasma urealyticum in acute and chronic nongonococcal urethritis. Clin Infect Dis. 2001;32(7):995–1003.CrossRef Horner P, Thomas B, Gilroy CB, Egger M, Taylor-Robinson D. Role of Mycoplasma genitalium and Ureaplasma urealyticum in acute and chronic nongonococcal urethritis. Clin Infect Dis. 2001;32(7):995–1003.CrossRef
5.
Zurück zum Zitat Vallely LM, Egli-Gany D, Pomat W, Homer CS, Guy R, Wand H, Silver B, Rumbold AR, Kaldor JM, Low N, et al. Adverse pregnancy and neonatal outcomes associated with Neisseria gonorrhoeae, Mycoplasma genitalium, M. hominis, Ureaplasma urealyticum and U. parvum: a systematic review and meta-analysis protocol. BMJ Open. 2018;8(11): e024175.CrossRef Vallely LM, Egli-Gany D, Pomat W, Homer CS, Guy R, Wand H, Silver B, Rumbold AR, Kaldor JM, Low N, et al. Adverse pregnancy and neonatal outcomes associated with Neisseria gonorrhoeae, Mycoplasma genitalium, M. hominis, Ureaplasma urealyticum and U. parvum: a systematic review and meta-analysis protocol. BMJ Open. 2018;8(11): e024175.CrossRef
6.
Zurück zum Zitat Capoccia R, Greub G, Baud D. Ureaplasma urealyticum, Mycoplasma hominis and adverse pregnancy outcomes. Curr Opin Infect Dis. 2013;26(3):231–40.CrossRef Capoccia R, Greub G, Baud D. Ureaplasma urealyticum, Mycoplasma hominis and adverse pregnancy outcomes. Curr Opin Infect Dis. 2013;26(3):231–40.CrossRef
7.
Zurück zum Zitat Weill FX, Le Hello S, Clerc M, Scribans C, de Barbeyrac B. Serological reactivity and bacterial genotypes in Chlamydia trachomatis urogenital infections in Guadeloupe, French West Indies. Sex Transm Infect. 2010;86(2):101–5.CrossRef Weill FX, Le Hello S, Clerc M, Scribans C, de Barbeyrac B. Serological reactivity and bacterial genotypes in Chlamydia trachomatis urogenital infections in Guadeloupe, French West Indies. Sex Transm Infect. 2010;86(2):101–5.CrossRef
8.
Zurück zum Zitat Ahmadi A, Ramazanzadeh R, Sayehmiri K, Sayehmiri F, Amirmozafari N. Association of Chlamydia trachomatis infections with preterm delivery; a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2018;18(1):240.CrossRef Ahmadi A, Ramazanzadeh R, Sayehmiri K, Sayehmiri F, Amirmozafari N. Association of Chlamydia trachomatis infections with preterm delivery; a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2018;18(1):240.CrossRef
9.
Zurück zum Zitat Heijne JCM, van den Broek IVF, Bruisten SM, van Bergen JEA, de Graaf H, van Benthem BHB. National prevalence estimates of chlamydia and gonorrhoea in the Netherlands. Sex Transm Infect. 2019;95(1):53–9.CrossRef Heijne JCM, van den Broek IVF, Bruisten SM, van Bergen JEA, de Graaf H, van Benthem BHB. National prevalence estimates of chlamydia and gonorrhoea in the Netherlands. Sex Transm Infect. 2019;95(1):53–9.CrossRef
12.
Zurück zum Zitat Li QH, Zhang Y, Zhao MM, Gu Y, Hu Y, Su YL, Zhang F, Shen L, Zhou Y, Li HP. Simultaneous amplification and testing method for Mycobacterium tuberculosis rRNA to differentiate sputum-negative tuberculosis from sarcoidosis. Am J Physiol Lung Cell Mol Physiol. 2019;316(3):L519–24.CrossRef Li QH, Zhang Y, Zhao MM, Gu Y, Hu Y, Su YL, Zhang F, Shen L, Zhou Y, Li HP. Simultaneous amplification and testing method for Mycobacterium tuberculosis rRNA to differentiate sputum-negative tuberculosis from sarcoidosis. Am J Physiol Lung Cell Mol Physiol. 2019;316(3):L519–24.CrossRef
13.
Zurück zum Zitat Leli C, Mencacci A, Latino MA, Clerici P, Rassu M, Perito S, Castronari R, Pistoni E, Luciano E, De Maria D, et al. Prevalence of cervical colonization by Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis and Mycoplasma genitalium in childbearing age women by a commercially available multiplex real-time PCR: an Italian observational multicentre study. J Microbiol Immunol Infect (Wei mian yu gan ran za zhi). 2018;51(2):220–5.CrossRef Leli C, Mencacci A, Latino MA, Clerici P, Rassu M, Perito S, Castronari R, Pistoni E, Luciano E, De Maria D, et al. Prevalence of cervical colonization by Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis and Mycoplasma genitalium in childbearing age women by a commercially available multiplex real-time PCR: an Italian observational multicentre study. J Microbiol Immunol Infect (Wei mian yu gan ran za zhi). 2018;51(2):220–5.CrossRef
14.
Zurück zum Zitat Kwak DW, Hwang HS, Kwon JY, Park YW, Kim YH. Co-infection with vaginal Ureaplasma urealyticum and Mycoplasma hominis increases adverse pregnancy outcomes in patients with preterm labor or preterm premature rupture of membranes. J Maternal-Fetal Neonat Med. 2014;27(4):333–7.CrossRef Kwak DW, Hwang HS, Kwon JY, Park YW, Kim YH. Co-infection with vaginal Ureaplasma urealyticum and Mycoplasma hominis increases adverse pregnancy outcomes in patients with preterm labor or preterm premature rupture of membranes. J Maternal-Fetal Neonat Med. 2014;27(4):333–7.CrossRef
15.
Zurück zum Zitat Li W, Fang YH, Shen HQ, Yang DH, Shu Q, Shang SQ. Evaluation of a real-time method of simultaneous amplification and testing in diagnosis of Mycoplasma pneumoniae infection in children with pneumonia. PLoS ONE. 2017;12(5): e0177842.CrossRef Li W, Fang YH, Shen HQ, Yang DH, Shu Q, Shang SQ. Evaluation of a real-time method of simultaneous amplification and testing in diagnosis of Mycoplasma pneumoniae infection in children with pneumonia. PLoS ONE. 2017;12(5): e0177842.CrossRef
16.
Zurück zum Zitat Ouzounova-Raykova V, Rangelov S, Ouzounova I, Mitov I. Detection of Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis in infertile Bulgarian men with multiplex real-time polymerase chain reaction. APMIS Acta Pathol Microbiol Immunol Scand. 2015;123(7):586–8.CrossRef Ouzounova-Raykova V, Rangelov S, Ouzounova I, Mitov I. Detection of Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis in infertile Bulgarian men with multiplex real-time polymerase chain reaction. APMIS Acta Pathol Microbiol Immunol Scand. 2015;123(7):586–8.CrossRef
17.
Zurück zum Zitat Jurstrand M, Jensen JS, Fredlund H, Falk L, Molling P. Detection of Mycoplasma genitalium in urogenital specimens by real-time PCR and by conventional PCR assay. J Med Microbiol. 2005;54(Pt 1):23–9.CrossRef Jurstrand M, Jensen JS, Fredlund H, Falk L, Molling P. Detection of Mycoplasma genitalium in urogenital specimens by real-time PCR and by conventional PCR assay. J Med Microbiol. 2005;54(Pt 1):23–9.CrossRef
18.
Zurück zum Zitat Cui Z, Wang Y, Fang L, Zheng R, Huang X, Liu X, Zhang G, Rui D, Ju J, Hu Z. Novel real-time simultaneous amplification and testing method to accurately and rapidly detect Mycobacterium tuberculosis complex. J Clin Microbiol. 2012;50(3):646–50.CrossRef Cui Z, Wang Y, Fang L, Zheng R, Huang X, Liu X, Zhang G, Rui D, Ju J, Hu Z. Novel real-time simultaneous amplification and testing method to accurately and rapidly detect Mycobacterium tuberculosis complex. J Clin Microbiol. 2012;50(3):646–50.CrossRef
19.
Zurück zum Zitat Chen Q, Hu Z, Zhang Q, Yu M. Development and evaluation of a real-time method of simultaneous amplification and testing of enterovirus 71 incorporating a RNA internal control system. J Virol Methods. 2014;196:139–44.CrossRef Chen Q, Hu Z, Zhang Q, Yu M. Development and evaluation of a real-time method of simultaneous amplification and testing of enterovirus 71 incorporating a RNA internal control system. J Virol Methods. 2014;196:139–44.CrossRef
20.
Zurück zum Zitat Qing L, Song QX, Feng JL, Li HY, Liu G, Jiang HH. Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium and Ureaplasma urealyticum infections using a novel isothermal simultaneous RNA amplification testing method in infertile males. Ann Clin Microbiol Antimicrob. 2017;16(1):45.CrossRef Qing L, Song QX, Feng JL, Li HY, Liu G, Jiang HH. Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium and Ureaplasma urealyticum infections using a novel isothermal simultaneous RNA amplification testing method in infertile males. Ann Clin Microbiol Antimicrob. 2017;16(1):45.CrossRef
21.
Zurück zum Zitat Dobson SR, McNeil S, Dionne M, Dawar M, Ogilvie G, Krajden M, Sauvageau C, Scheifele DW, Kollmann TR, Halperin SA, et al. Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. JAMA. 2013;309(17):1793–802.CrossRef Dobson SR, McNeil S, Dionne M, Dawar M, Ogilvie G, Krajden M, Sauvageau C, Scheifele DW, Kollmann TR, Halperin SA, et al. Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. JAMA. 2013;309(17):1793–802.CrossRef
Metadaten
Titel
Analysis of Ureaplasma urealyticum, Chlamydia trachomatis, Mycoplasma genitalium and Neisseria gonorrhoeae infections among obstetrics and gynecological outpatients in southwest China: a retrospective study
verfasst von
Ting Liu
Shu-yu Lai
Wei Zhou
Yan-ling Liu
Sha-sha Chen
Yong-mei Jiang
Publikationsdatum
01.12.2022
Verlag
BioMed Central
Erschienen in
BMC Infectious Diseases / Ausgabe 1/2022
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-021-06966-z

Weitere Artikel der Ausgabe 1/2022

BMC Infectious Diseases 1/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.